Pathstone Family Office, LLC Amicus Therapeutics, Inc. Call Options Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding FOLD
# of Institutions
274Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$294 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$292 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$285 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$238 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$196 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.92B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...